- Home
- KURA vs REAL Comparison
KURA vs REAL Comparison
Compare KURA & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- REAL
- Stock Information
- Founded
- KURA 2014
- REAL 2011
- Country
- KURA United States
- REAL United States
- Employees
- KURA N/A
- REAL N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- REAL Other Specialty Stores
- Sector
- KURA Health Care
- REAL Consumer Discretionary
- Exchange
- KURA Nasdaq
- REAL Nasdaq
- Market Cap
- KURA 592.7M
- REAL 554.6M
- IPO Year
- KURA N/A
- REAL 2019
- Fundamental
- Price
- KURA $6.37
- REAL $5.77
- Analyst Decision
- KURA Strong Buy
- REAL Buy
- Analyst Count
- KURA 10
- REAL 6
- Target Price
- KURA $25.50
- REAL $8.00
- AVG Volume (30 Days)
- KURA 1.5M
- REAL 2.9M
- Earning Date
- KURA 05-01-2025
- REAL 05-08-2025
- Dividend Yield
- KURA N/A
- REAL N/A
- EPS Growth
- KURA N/A
- REAL N/A
- EPS
- KURA N/A
- REAL N/A
- Revenue
- KURA $53,883,000.00
- REAL $600,484,000.00
- Revenue This Year
- KURA $44.32
- REAL $11.35
- Revenue Next Year
- KURA $173.73
- REAL $9.35
- P/E Ratio
- KURA N/A
- REAL N/A
- Revenue Growth
- KURA N/A
- REAL 9.32
- 52 Week Low
- KURA $5.41
- REAL $2.24
- 52 Week High
- KURA $23.48
- REAL $11.38
- Technical
- Relative Strength Index (RSI)
- KURA 48.18
- REAL 52.46
- Support Level
- KURA $5.64
- REAL $5.02
- Resistance Level
- KURA $6.11
- REAL $5.40
- Average True Range (ATR)
- KURA 0.39
- REAL 0.49
- MACD
- KURA 0.10
- REAL 0.10
- Stochastic Oscillator
- KURA 81.01
- REAL 84.67
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.